Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe

Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research AMSTERDAM and MADRID and CARLSBAD, Calif. -- Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing [...]

Simulations Plus Announces Senior Management Changes

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced changes in its senior management structure. Walt Woltosz, chairman and chief executive officer of Simulations Plus, Inc., said, “The board of directors has appointed Mr. John DiBella president of the Lancaster, California division, known as [...]

Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe

Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research AMSTERDAM and MADRID and CARLSBAD, Calif. -- Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing [...]

Accomplish more with our new Fluoracle® software feature

We are delighted to announce the arrival of a new batch measurement option to our Fluoracle software for the FS5 spectrofluorometer and FLS1000 Fluorescence Spectrometer. Fluoracle now features a new batch measurement wizard in addition to all the standard instrument control and analysis options. Batch acquisition enables our customers to design a sequence of multiple different measurements [...]

Xeno-free Cell Culture Medium for Regenerative Medicine Research

AMSBIO announces the availability of StemFit® Basic02 feeder-free stem cell culture media. Stem cells and genome editing offer exciting opportunities within regenerative medicine. However, any clinical application of stem cells requires strict regulation to ensure that the cells are not exposed to  animal derived products. StemFit® Basic02 is a xeno-free, defined medium for human pluripotent stem [...]

Labcyte and SEngine Precision Medicine Collaborate to Offer Functional Drug Screening for Oncology

SAN JOSE, CA, and SEATTLE, WA Labcyte Inc. and SEngine Precision Medicine today announced the companies are collaborating to fulfill the promise of personalized medicine by employing Labcyte’s advanced acoustic liquid handling solutions with SEngine’s unique functional drug testing approach with the mission to match cancer patients to the most effective and least toxic therapies available. SEngine employs functional [...]

Shimadzu’s New EDX-8100 Energy Dispersive X-Ray Fluorescence Spectrometer Enables Analysis of Liquid Samples with High Sensitivity by Helium Purging

Shimadzu announces the release of the EDX-8100 energy dispersive X-ray fluorescence spectrometer. This instrument offers enhanced versatility with the ability to analyze even light elements in liquid samples with high sensitivity by helium purging. In addition to retaining the excellent analysis capabilities, operability, and expandability of the EDX-8000 energy dispersive X-ray fluorescence spectrometer, the product’s [...]

Announcement of Establishment of JEOL-Nikon CLEM Solution Center

JEOL Ltd. (President Gon-emon Kurihara) is pleased to announce the “JEOL-Nikon CLEM Solution Center”, a collaborative project between Nikon and JEOL Ltd., will be established on September 1, 2017. The center will be opened in the R & D Building of JEOL to provide experience in and collect and deliver technical information on cutting-edge CLEM* [...]

First FDA-Approved Cell Therapy for Leukemia Utilizes Thermo Fisher Scientific’s CTS Dynabeads Technology

Kymriah™ (tisagenlecleucel, formerly CTL019), the first FDA-approved CAR-T cell therapy, uses CTS Dynabeads CD3/CD28 spherical beads to isolate, activate and expand T cells WALTHAM, Mass. -- The U.S. Food and Drug Administration (FDA) has approved a new cell therapy for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia [...]

ExcitePCR Announces its FireflyDX-Portable: A Lightweight, Bookbag-sized Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018

Recent market developments inspire ExcitePCR management to expand its product strategy to a planned rollout of a FireflyDX family of realtime pathogen detection systems, with the FireflyDX-Portable launch scheduled for the summer of 2018 and the FireflyDX-Handheld targeted for availability in 2019 Pleasanton, Calif. ExcitePCR™ today announced the FireflyDX-Portable™, a rechargeable bookbag-sized realtime pathogen detection [...]

Access IBO on Knowledge Center